Avro Life Science

Avro Life Science is a clinical stage biotech company located in Waterloo, Ontario, Canada. With a team of 8 employees, Avro operates primarily in the healthcare industry, under the sub-industry of Drug Discovery and Delivery. The company is known for its innovative approach in developing skin patches that facilitate the passive delivery of generic drugs through the skin. Avro Life Science was part of the Y Combinator W18 batch and maintains affiliations with several prestigious organizations including Bayer, Y Combinator, Thiel Fellowship, Velocity, Creative Destruction Lab, University of Waterloo, Mitacs, OCE, and California Life Sciences. The company has developed the first topical platform technology, which enables novel classes of drugs to be delivered into the skin, redefining the skin’s potential as a therapeutic vector. Its product pipeline includes the TopiqIL Platform, TransdermIL Platform, AVR 235, and AVR 335, marking significant advancements in transdermal drug delivery systems.